569 related articles for article (PubMed ID: 23192415)
1. Depletion of β-arrestin2 in hepatic stellate cells reduces cell proliferation via ERK pathway.
Sun WY; Song Y; Hu SS; Wang QT; Wu HX; Chen JY; Wei W
J Cell Biochem; 2013 May; 114(5):1153-62. PubMed ID: 23192415
[TBL] [Abstract][Full Text] [Related]
2. TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways.
Fang L; Zhan S; Huang C; Cheng X; Lv X; Si H; Li J
Toxicol Appl Pharmacol; 2013 Nov; 272(3):713-25. PubMed ID: 23958495
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of extracellular signal-regulated kinase 1 by adenovirus mediated small interfering RNA attenuates hepatic fibrosis in rats.
Zhong W; Shen WF; Ning BF; Hu PF; Lin Y; Yue HY; Yin C; Hou JL; Chen YX; Zhang JP; Zhang X; Xie WF
Hepatology; 2009 Nov; 50(5):1524-36. PubMed ID: 19787807
[TBL] [Abstract][Full Text] [Related]
4. Cellular crosstalk mediated by platelet-derived growth factor BB and transforming growth factor β during hepatic injury activates hepatic stellate cells.
Mekala S; Tulimilli SV; Geesala R; Manupati K; Dhoke NR; Das A
Can J Physiol Pharmacol; 2018 Aug; 96(8):728-741. PubMed ID: 29558627
[TBL] [Abstract][Full Text] [Related]
5. Hesperetin derivative-7 inhibits PDGF-BB-induced hepatic stellate cell activation and proliferation by targeting Wnt/β-catenin pathway.
Lin X; Kong LN; Huang C; Ma TT; Meng XM; He Y; Wang QQ; Li J
Int Immunopharmacol; 2015 Apr; 25(2):311-20. PubMed ID: 25701506
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
7. Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells.
Peng Y; Yang H; Wang N; Ouyang Y; Yi Y; Liao L; Shen H; Hu G; Wang Z; Tao L
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G253-63. PubMed ID: 24337009
[TBL] [Abstract][Full Text] [Related]
8. MeCP2 silencing of LncRNA H19 controls hepatic stellate cell proliferation by targeting IGF1R.
Yang JJ; Liu LP; Tao H; Hu W; Shi P; Deng ZY; Li J
Toxicology; 2016 Jun; 359-360():39-46. PubMed ID: 27350269
[TBL] [Abstract][Full Text] [Related]
9. Altered factor VII activating protease expression in murine hepatic fibrosis and its influence on hepatic stellate cells.
Roderfeld M; Weiskirchen R; Atanasova S; Gressner AM; Preissner KT; Roeb E; Kanse SM
Liver Int; 2009 May; 29(5):686-91. PubMed ID: 19018983
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
[TBL] [Abstract][Full Text] [Related]
11. Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats.
Chen SW; Chen YX; Zhang XR; Qian H; Chen WZ; Xie WF
Gene Ther; 2008 Nov; 15(21):1424-35. PubMed ID: 18509379
[TBL] [Abstract][Full Text] [Related]
12. Saikosaponin A of Bupleurum chinense (Chaihu) elevates bone morphogenetic protein 4 (BMP-4) during hepatic stellate cell activation.
Wang X; Wang Q; Burczynski FJ; Kong W; Gong Y
Phytomedicine; 2013 Nov; 20(14):1330-5. PubMed ID: 23969230
[TBL] [Abstract][Full Text] [Related]
13. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.
Li J; Liu P; Zhang R; Cao L; Qian H; Liao J; Xu W; Wu M; Yin Z
J Ethnopharmacol; 2011 Sep; 137(1):714-23. PubMed ID: 21726622
[TBL] [Abstract][Full Text] [Related]
14. Ligustrazine attenuates oxidative stress-induced activation of hepatic stellate cells by interrupting platelet-derived growth factor-β receptor-mediated ERK and p38 pathways.
Zhang F; Ni C; Kong D; Zhang X; Zhu X; Chen L; Lu Y; Zheng S
Toxicol Appl Pharmacol; 2012 Nov; 265(1):51-60. PubMed ID: 23022513
[TBL] [Abstract][Full Text] [Related]
15. α-Lipoic acid inhibits liver fibrosis through the attenuation of ROS-triggered signaling in hepatic stellate cells activated by PDGF and TGF-β.
Foo NP; Lin SH; Lee YH; Wu MJ; Wang YJ
Toxicology; 2011 Mar; 282(1-2):39-46. PubMed ID: 21251946
[TBL] [Abstract][Full Text] [Related]
16. The tyrosine phosphatase SHP-1 inhibits proliferation of activated hepatic stellate cells by impairing PDGF receptor signaling.
Tibaldi E; Zonta F; Bordin L; Magrin E; Gringeri E; Cillo U; Idotta G; Pagano MA; Brunati AM
Biochim Biophys Acta; 2014 Feb; 1843(2):288-98. PubMed ID: 24140598
[TBL] [Abstract][Full Text] [Related]
17. Gremlin1 Accelerates Hepatic Stellate Cell Activation Through Upregulation of TGF-Beta Expression.
Zhang YQ; Wan LY; He XM; Ni YR; Wang C; Liu CB; Wu JF
DNA Cell Biol; 2017 Jul; 36(7):603-610. PubMed ID: 28467108
[TBL] [Abstract][Full Text] [Related]
18. The antihepatic fibrotic effects of fluorofenidone via MAPK signalling pathways.
Peng Y; Yang H; Zhu T; Zhao M; Deng Y; Liu B; Shen H; Hu G; Wang Z; Tao L
Eur J Clin Invest; 2013 Apr; 43(4):358-68. PubMed ID: 23438945
[TBL] [Abstract][Full Text] [Related]
19. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
[TBL] [Abstract][Full Text] [Related]
20. Role of growth factor receptor-bound 2 in CCl
Ge S; Xiong Y; Wu X; Xie J; Liu F; He J; Xiang T; Cheng N; Lai L; Zhong Y
Biomed Pharmacother; 2017 Aug; 92():942-951. PubMed ID: 28618656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
